| [1] |
Singer PA, Crooper DS, Levy EC, et al. Treatment guidelines for patients with hyperthyroidism and hypothyoidism. JAMA, 1995,273(10):808-812.
|
| [2] |
李险峰,晋建华,张东红,等.甲状腺疾病131I治疗的辐射危害评价.中华核医学杂志,2004,24(3):191.
|
| [3] |
Coover LR, Silberstein EB, Kuhn PJ, et al. Therapeutic 131Ⅰ in outpatients:a simplified method conforming to the code of federal regulations, title 10, part 35.75. J Nucl Med, 2000, 41(11):1868-1875.
|
| [4] |
US Nuclear Regulatory Commission. 10 CFR Part 35.75:Release of individuals containing unsealed byproduct material or implants containing byproduct material. Washington DC:US Government Printing Office, 2000.
|
| [5] |
Friedman MI, Ghesani M. Interactive software automates personalized radiation safety plans for Na131Ⅰ therapy. Health Phys,2002, 83(11Suppl):S71-S84.
|